Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study to Assess Safety, Tolerability and Efficacy of Afabicin in The Treatment of Participants With Bone or Joint Infection Due to Staphylococcus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03723551
Recruitment Status : Active, not recruiting
First Posted : October 29, 2018
Last Update Posted : November 28, 2019
Sponsor:
Information provided by (Responsible Party):
Debiopharm International SA

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : July 23, 2020
Estimated Study Completion Date : July 23, 2020